Skip to content

Effect of Esketamine on Early Postpartum Blues in Cesarean Section Patients: A Randomized Double-Blind Controlled Trial

Effect of Esketamine on Early Postpartum Blues in Cesarean Section Patients: A Randomized Double-Blind Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113071
Enrollment
Unknown
Registered
2025-11-24
Start date
2025-11-25
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Blues

Interventions

Experimental: Esketamine Group:After umbilical cord clamping, the investigational drug was initiated via intravenous infusion. The agent was diluted in 20 mL of normal saline and administered at a rat
Placebo Control: Normal Saline Group:After umbilical cord clamping, an equivalent volume of normal saline was infused at the same infusion rate and for the same duration as in the experimental group.

Sponsors

Huzhou Maternity & Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 45 years; 2.Full-term pregnancy; 3.Pre-pregnancy body mass index (BMI) of 18.5–40 kg/m^2; 4.Medically healthy with stable cardiovascular vital signs; 5.American Society of Anesthesiologists (ASA) physical status I–III; 6.Scheduled for elective cesarean section at Huzhou Maternity & Child Health Care Hospital; 7.Capable of understanding study procedures and assessment instruments, and able to communicate effectively with research personnel; 8. Provides voluntary informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.History of mental illness ( such as depression, schizophrenia, etc. ) or communication disorders; 2.Serious pregnancy complications ( such as severe preeclampsia, placenta implantation, HELLP syndrome, placenta previa, placental abruption, etc. ); 3.Contraindications to S-ketamine ( such as refractory or refractory hypertension, severe cardiovascular disease [ cardiac function grade = grade III ], hyperthyroidism, etc. ); 4.Current use of medications that influence mood or treat conditions associated with mood instability; 5.Disorders of reproductive hormone metabolism or recent hormonal therapy; 6.Presence of significant preoperative depression risk factors (e.g., prolonged exposure to domestic violence, recent bereavement); 7.Those who refused to participate in the experiment.

Design outcomes

Secondary

MeasureTime frame
Profile of Mood States (POMS);Stein Maternity Blues Scale Score;Postpartum Depression;Postoperative Pain;Postoperative Sleep Quality;

Primary

MeasureTime frame
Change in depressive mood, representing the severity of PPB;

Countries

China

Contacts

Public ContactQin Cheng

Huzhou Maternity & Child Health Care Hospital

chengqian1726@163.com+86 158 6828 4766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026